Matrine

Overview

Matrine is a tetracyclic quinolizidine alkaloid primarily isolated from the roots of Sophora flavescens (Kushen) and related Sophora species, which have been used in traditional Chinese medicine for over 2,000 years to treat dysentery, eczema, and various inflammatory conditions. In modern pharmacological research, matrine and its oxidized derivative oxymatrine have emerged as compounds of significant therapeutic interest due to their broad-spectrum biological activities spanning anti-inflammatory, anti-tumor, antiviral, antifibrotic, and immunomodulatory effects — activities that are remarkable in scope for a single natural alkaloid.

The anti-tumor properties of matrine have been the most extensively studied, with research demonstrating growth inhibition and apoptosis induction across a wide range of cancer cell lines including hepatocellular carcinoma, gastric cancer, breast cancer, lung cancer, and leukemia. Mechanistically, matrine triggers apoptosis through both intrinsic (mitochondrial) and extrinsic (death receptor) pathways, inhibits NF-kB and PI3K/Akt signaling, induces cell cycle arrest at G0/G1 or G2/M phases, suppresses tumor angiogenesis, and promotes autophagy-mediated cell death. In hepatology, oxymatrine is approved in China as an injectable treatment for chronic hepatitis B, where it demonstrates both direct antiviral activity and hepatoprotective effects through reduction of liver inflammation and fibrosis. The compound inhibits hepatic stellate cell activation and collagen deposition via TGF-beta/Smad pathway modulation.

Matrine's anti-inflammatory mechanism involves suppression of the JAK/STAT signaling cascade, inhibition of MAPK phosphorylation, and downregulation of pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). These effects have shown therapeutic potential in autoimmune and inflammatory conditions including inflammatory bowel disease, rheumatoid arthritis, and atopic dermatitis in preclinical models. Dosing in clinical practice (primarily in China) ranges from 100–200 mg orally or 100–150 mg intravenously for oxymatrine. Side effects may include gastrointestinal discomfort, dizziness, and at higher doses, hepatotoxicity — paradoxically, given the compound's hepatoprotective effects at therapeutic levels. Matrine remains primarily a research compound outside of Chinese clinical practice and is not widely available as a consumer supplement in Western markets.

Mechanism of Action

Matrine is a tetracyclic quinolizidine alkaloid derived from Sophora flavescens that exerts broad pharmacological effects through modulation of multiple oncogenic and inflammatory signaling pathways. Its antitumor activity centers on suppression of the PI3K/Akt/mTOR axis, reducing phosphorylation of Akt and downstream effectors including p70S6K and 4E-BP1, thereby inhibiting tumor cell proliferation, protein synthesis, and survival signaling. Matrine simultaneously inhibits the MAPK/ERK pathway by reducing Ras-Raf-MEK-ERK phosphorylation cascades, and suppresses Wnt/beta-catenin signaling by promoting beta-catenin degradation, which is critical for blocking epithelial-mesenchymal transition (EMT) and cancer cell metastasis.

Matrine induces programmed cell death through multiple mechanisms: it triggers intrinsic (mitochondrial) apoptosis by upregulating pro-apoptotic Bax, downregulating anti-apoptotic Bcl-2, promoting cytochrome c release, and activating caspase-9 and caspase-3 cascades. It also induces autophagy through AMPK activation and mTOR inhibition, and promotes pyroptosis via NLRP3 inflammasome activation in certain cancer types. Anti-inflammatory effects are mediated through potent inhibition of NF-kB nuclear translocation by blocking IKK-mediated IkB-alpha phosphorylation, reducing expression of COX-2, iNOS, TNF-alpha, and IL-6. Matrine also inhibits JAK/STAT3 signaling, disrupting STAT3 dimerization and nuclear translocation required for tumor cell survival gene expression.

These multi-pathway actions give matrine therapeutic potential in hepatocellular carcinoma, breast cancer, lung cancer, and leukemia, as well as in inflammatory conditions including hepatic fibrosis, colitis, and cardiac inflammation. Matrine remodels the tumor immune microenvironment by promoting CD8+ T cell infiltration and reducing regulatory T cell populations, suggesting immunomodulatory anticancer potential.

Reconstitution Calculator

Research

Safety Profile

Matrine has limited human safety data, so caution is advised. Potential side effects may include anxiety and derealization, possibly due to kappa-opioid receptor activity. There is also a theoretical concern for 5-alpha reductase inhibition. No specific contraindications are established, but use should be approached carefully given the lack of clinical studies.

Pharmacokinetic Profile